Vaccinations and Immunisations

If you are eligible for a  Spring booster  you can book for via this link: https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/book-coronavirus-vaccination/ Alternatively you can call 119 for help with booking this vaccination

JCVI’s interim advice for planning purposes ahead of 2023 is that:

• in autumn 2023, persons at higher risk of severe COVID-19 could be offered a booster vaccine dose in preparation for winter 2023 to 2024
• in addition, for a smaller group of persons (such as persons of older age and those who are immunosuppressed) an extra booster vaccine dose may be offered in spring 2023
• emergency surge vaccine responses may be required should a novel variant of concern emerge with clinically significant biological differences compared to the Omicron variant

JCVI also advises that:

• the 2021 booster offer (third dose) for persons aged 16 to 49 years who are not in a clinical risk group should close in alignment with the close of the autumn 2022 vaccination campaign^{[footnote 1]}
• otherwise healthy persons aged 5 to 49 years who develop a new health condition in 2023 that places them in a clinical risk group would be offered primary vaccination and/or a booster vaccine during the next seasonal vaccination campaign, as appropriate. Vaccination outside these campaign periods would be subject to individual clinical judgement
• primary course COVID-19 vaccination should move, over the course of 2023, towards a more targeted offer during vaccination campaigns to protect those persons at higher risk of severe COVID-19. This would include:
  • residents in a care home for older adults and staff working in care homes for older adults
  • frontline health and social care workers
  • all adults aged 50 years and over
  • persons aged 5 to 49 years in a clinical risk group, as set out in the Green Book
  • persons aged 12 to 49 years who are household contacts of people with immunosuppression
  • persons aged 16 to 49 years who are carers, as set out in the Green Book
• research should be considered to inform the optimal timing of booster vaccinations to protect against severe COVID-19 (hospitalisations and deaths) for groups who are at different levels of clinical risk